Cassiopea Partners acted as sole financial advisor to White Bridge Investments and Biofarma Group (“Biofarma”) in the acquisition of a majority stake in International Health Science (“IHS” or the “Business Unit”), the finished products business division of Giellepi S.p.A. (“Giellepi”) and Italian leader in the development of nutraceutical dietary...
Archive for month: December, 2021
Recent Posts
- Cassiopea Partners advises IBF Servizi S.p.A, a Nextalia Portfolio company, in the acquisition of Abaco S.p.A., the European leader in agritech software solutions
- Cassiopea Partners advises Montanstahl AG in the acquisition of Siderval S.p.A., a manufacturer of hot extruded steel profiles
- Cassiopea Partners advises infrastructure funds Eurizon ITEᴙ and Equiter in the acquisition of Tecnofer
- Cassiopea Partners advises Cantiere del Pardo and its shareholders on the sale of a majority stake to Calzedonia Group
- Cassiopea Partners advises Balich Wonder Studio and its shareholders on the sale of a majority stake to Banijay
Archives
- October 2023
- August 2023
- June 2023
- May 2023
- February 2023
- December 2022
- November 2022
- September 2022
- March 2022
- January 2022
- December 2021
- October 2021
- May 2021
- January 2021
- December 2020
- November 2020
- September 2020
- August 2020
- July 2019
- July 2018
- June 2018
- January 2018
- December 2017
- October 2017
- July 2017
- June 2017
- April 2017
- February 2016
- July 2015
- March 2014
- December 2013
- June 2013
- September 2012